Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients

International Archives of Allergy and Immunology

Volumn 141, Issue 4, 2006, Pages 369-376

  Tabar, Ana Isabel ^a   Anda, Marta ^a   Bonifazi, Floriano ^b   Bilò, Maria Beatrice ^b   Leynadier, Francisque ^c   Fuchs, Thomas ^e   Ring, Johannes ^f   Galvain, Sylvie ^d   André, Claude ^d  

^a Universidad Pública de Navarra   (Spain)

^b Azienda Ospedaliera Umberto I   (Italy)

^c HÔPITAL TENON   (France)

^d Stallergenes SA   (France)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Asthma; Latex; Rhinoconjunctivitis; Specific immunotherapy; Urticaria

Indexed keywords

ADRENALIN; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LATEX; STEROID;

ABDOMINAL PAIN; ADULT; ALLERGY; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ECZEMA; EDEMA; FEMALE; HAND PALM; HUMAN; IMMUNOTHERAPY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PALM ITCHING; PRICK TEST; PRIORITY JOURNAL; PROVOCATION; PRURITUS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCORING SYSTEM; SNEEZING; SPECIFIC IMMUNOTHERAPY; SYMPTOM; THROAT DISEASE; THROAT ITCHING; URTICARIA;

ADULT; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LATEX; LATEX HYPERSENSITIVITY; MALE; MIDDLE AGED; SKIN TESTS;

EID: 33751234781     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095463     Document Type: Article

References (30)

1. Cantani A: Latex allergy in children. Invest Allergol Clin Immunol 1999;9:14-20.
2. Frankland AW: Latex allergy. Clin Exp Allergy 1995;25:199-201.
3. Spaner D, Dolovich J, Tarlo S, Sussman G, Buttoo K: Hypersensitivity to natural latex. J Allergy Clin Immunol 1989;83:1135-1137.
4. Gritter M: Latex Allergy. Lippincott Primary Care Pract 1997;1:142-151.
5. Levy DA, Charpin D, Pecquet C, Leynadier F, Vervloet D: Allergy to latex. Allergy 1992;47:579-587.
6. Slater JE, Chhabra SK: Latex antigens. J Allergy Clin Immunol 1992;89:673-678.
7. Turjanmaa K, Mäkinen-Kiljunen S, Reunala T, Alenius H, Palosuo T: Natural rubber latex allergy - the European experience. Immunol Allergy Clin North Am 1995;15:71-88.
8. Kwittken PL, Sweinberg SK, Campbell DE, Pawlowski NA: Latex hypersensitivity in children: clinical presentation and detection of latex-specific immunoglobulin E. Pediatrics 1995;95:693-699.
9. Fuchs T, Spitzauer S, Vente C, Hevier J, Kapiotis S, Rumpold H, et al: Natural latex, grass pollen, and weed pollen share IgE epitopes. J Allergy Clin Immunol 1997;100:1-16.
10. Mäkinen-Kiljunen S: Banana allergy in patients with immediate-type hypersensitivity to natural rubber latex: characterization of cross-reacting antibodies and allergens. J Allergy Clin Immunol 1994;93:990-996.
11. Nel A, Gujuluva C: Latex antigens: identification and use in clinical and experimental studies, including crossreactivity with food and pollen allergens. Ann Allergy Asthma Immunol 1998;81:388-398.
12. Mathew SN, Melton AL, Wagner WO: Latex hypersensitivity: a case study. Ann Allergy 1993;70:483-486.
13. Blanco C, Carrillo T, Castillo R, Quiralte J, Cuevas M: Latex allergy: clinical features and cross-reactivity with fruits. Ann Allergy 1994;73:309-314.
14. Hunt LW, Kelkar P, Reed CE, Yunginger JW: Management of occupational allergy to natural rubber latex in a medical center: the importance of quantitative latex allergen measurement and objective follow-up. J Allergy Clin Immunol 2002;110:S96-S106.
15. Turjanmaa K, Kanto M, Kautiainen H, Reunala T, Palosuo T: Long-term outcome of 160 adult patients with natural rubber latex allergy. J Allergy Clin Immunol 2002;110:S70-S74.
16. Bernstein DI, Karnani R, Biagini RE, Bernstein CK, Murphy K, Berendts B, Bernstein JA: Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann Allergy Asthma Immunol 2003;90:209-213.
17. Pereira C, Rico P, Lourenço M, Lombardero M, Pinto-Mendes J, Chieira C: Specific immunotherapy for occupational latex allergy. Allergy 1999;54:287-296.
18. Pereira C, Pedro E, Tavares B, Ferreira MB, Carrapatoso I, Rico P, et al: Specific immunotherapy for severe latex allergy. Eur Ann Allergy Clin Immunol 2003;35:217-225.
19. Leynadier F, Herman D, Verloet D, Andre C: Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol 2000;106:585-590.
20. Sastre J, Fernandez-Nieto M, Rico P, Martin S, Barber D, Cuesta J, et al: Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2003;111:985-994.
21. Aas K: Heterogeneity of bronchial asthma. Sub-populations or different stages of the disease. Allergy 1981;36:3-14.
22. Turjanmaa K, Palosuo T, Alenius H, Leynadier F, Autegarden JE, André C, et al: Latex allergy diagnosis: in vivo and in vitro standardization of a natural rubber latex extract. Allergy 1997;52:41-50.
23. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797-802.
24. Abelson MB, Chambers WA, Smith LM: Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990;108:84-88.
25. Malling H-J, Weeke B: Immunotherapy. Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 1993;48(suppl 14):9-35.
26. Toci G, Shah S, Al-Faqih A, Beezhold D, McGeady SJ: Oral latex desensitization of healthcare workers (abstract). J Allergy Clin Immunol 1998;101:S161.
27. Patriarca G, Nucera E, Pollastrini E, Roncallo C, Buonomo A, Bartolozzi F, et al: Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg 2002;95:956-960.
28. Cistero Bahima A, Sastre J, Enrique E, Fernandez M, Alonso R, Quirce S, et al: Tolerance and effects on skin reactivity to latex of sublingual rush immunotherapy with a latex extract. J Investig Allergol Clin Immunol 2004;14:17-25.
29. Drew AC, Eusebius NP, Kenins L, de Silva HD, Suphioglu C, Rolland JM, O'Hehir RE: Hypoallergenic variants of the major latex allergen Hev b 6.01 retaining human T lymphocyte reactivity. J Immunol 2004;173:5872-5879.
30. Karisola P, Mikkola J, Kalkkinen N, Airenne KJ, Laitinen OH, Repo S, Pentikäinen OT, Reunala T, Turjanmaa K, Johnson MS, Palosuo T, Kulomaa MS, Alenius H: Construction of hevein (Hev b 6.02) with reduced allergenicity for immunotherapy of latex allergy by comutation of six amino acid residues on the conformational IgE epitopes. J Immunol 2004;172:2621-2628.